Isan Chen

12.4k citations
30 papers · 9.7k · 4 hit papers · h-index 18

Impact in

Papers in

    • Renal cell carcinoma treatment 10
    • Prostate Cancer Treatment and Research 5
    • Advanced Breast Cancer Therapies 4
    • Cancer-related Molecular Pathways 5
    • Cancer Treatment and Pharmacology 3
    • Cancer Immunotherapy and Biomarkers 3

Isan Chen

29 papers receiving 9.4k citations

Isan Chen's Hit Papers

A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509 2013 · 467 citations
4670+6+12Years since publication10002.0k3.0k4.0k

Peers

Isan Chen
Comparison fields: 5 of 104
  • Pulmonary and Respiratory Medicine 6.5k
  • Cancer Research 2.2k
  • Oncology 2.7k
  • Molecular Biology 3.5k
  • Genetics 308
Replace Gary R. Hudes with:
Gary R. Hudes United States
Sindy T. Kim United States
Viktor Grünwald Germany
Frédéric Rolland France
Sara M. Haserlat United States
Paul W. Bycott United States
Hidefumi Sasaki Japan
Paula K. Herman United States
Juliann Chmielecki United States
Apurva A. Desai United States
Isan Chen relative to Gary R. Hudes United States Gary R. Hudes's profile →
Citations per field
00.5×1.7×
Gary R. Hudes · 1×
Citations per year

Countries citing papers authored by Isan Chen

Since Specialization
Citations

This map shows the geographic impact of Isan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isan Chen more than expected).

Fields of papers citing papers by Isan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isan Chen. The network helps show where Isan Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Isan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Isan Chen Line = papers co-authored together Isan Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Hit paper breakdown →
20074715
2
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Hit paper breakdown →
20091804
3
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Hit paper breakdown →
20091107
4
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
Hit paper breakdown →
2013467
5 2008336
6 2013215
7 2009171
8 2005158
9 2004103
10 200899
11 200888
12 201277
13 200970
14 201463
15 201338
16 200934
17 200633
18 201024
19 202313
20 200612

About Isan Chen

Isan Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Cell Biology and Molecular Biology, having authored 30 papers that have together received 9.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Cancer-related Molecular Pathways (5 papers), Prostate Cancer Treatment and Research (5 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.5k citations), Cancer Research (2.2k citations), Oncology (2.7k citations), Molecular Biology (3.5k citations) and Genetics (308 citations). Isan Chen has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Sindy T. Kim, Marc Dror Michaelson, Ronald M. Bukowski, Thomas E. Hutson, Robert John Motzer, Cezary A. Szczylik, Piotr Tomczak, Robert A. Figlin, Sylvie Négrier and Stéphane Marie. Oudard. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Genitourinary Cancer, New England Journal of Medicine and eLife.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact